Research Interests
Design, conduct and analysis of multicenter clinical trials, interim monitoring of clinical trial data, multiple endpoints.
Selected Publications
Roecker EB: Prediction error and its estimation for subset-selected models. Technometrics 33:459-468, 1991.
Zimmerman SW, Ahrens E, Johnson CA, Craig W, Leggett J, O'Brien M, Oxton L, Roecker EB, Engeseth S: Randomized, controlled trial of prophylactic rifampin for peritoneal dialysis related infection. American Journal of Kidney Disease 2:225-231, 1991.
Pirsch JD, D'Alessandro AM, Sollinger HW, Hoffman RM, Roecker EB, Voss BJ, Lorentzen DF, Knechtle SJ, Reed A, Kalayoglu M, and Belzer FO: The effect of donor age, recipient age, and HLA match on immunologic graft survival in cadaver renal transplant recipients. Transplantation 53:55-59, 1992.
Roecker EB, Pulos E, Bresnick GH, Severns M: Characterization of the ERG scotopic B-wave amplitude in diabetic and normal subjects. Investigative Ophthalmology & Visual Science 33:1575-1583, 1992.
Messing EM, Young TB, Hunt VB, Roecker EB, Vaillancourt AM, Crowley WP, Greenberg EB, Kuglitsch ME, Wegenke JD: Home screening for hematuria: Results of a multi-clinic study. Journal of Urology 148:289-292, 1992.
Kemnitz JW, Weindruch R, Roecker EB, Crawford K, Kaufman PL, and Ershler WB: Dietary restriction of adult male Rhesus monkeys: Design, methodology and preliminary findings from the first year of study. Journal of Gerontology 48:B17-B26, 1993.
Pirsch JD, D'Alessandro AM, Roecker EB, Knechtle SJ, Reed A, Sollinger HW, Kalayoglu M and Belzer FL: A controlled double blind randomized trial of verapamil and cyclosporine in cadaver renal transplant patients. American Journal of Kidney Diseases 21:189-195, 1993.
Oxton LL, Zimmerman SW, Roecker EB, Wakeen M: Risk factors for peritoneal dialyses related infections. Peritoneal Dialysis International 14:137-144, 1994.
Rosenbek JC, Robbins J, Roecker EB, Coyle JL, Wood JL: A penetration-aspiration scale. Dysphagia 11:93-98, 1996.
Rosenbek J, Roecker EB, Wood JL, Robbins J: Thermal application reduces the duration of stage transition in dysphagia after stroke. Dysphagia 11:225-223, 1996.
Robbins J, Coyle J, Rosenbek J, Roecker EB, Wood J: Differentiation of normal and abnormal airway protection during swallowing using the penetration aspiration scale. Dysphagia, 14:228-232,1999.
O'Neill WW, Serruys P, Knudtson M, van Es GA, Timmis GC, van der Zwann C, Kleiman J, Gong J, Roecker EB, Dreiling R, Alexander J, Anders R: Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. New England Journal of Medicine 342:1316-1324, 2000.
Fisher MR, Roecker EB, DeMets DL: The role of an independent statistical analysis center in the industry-modified National Institutes of Health model. Drug Information Journal 35:115-129, 2001.
Packer M, Coats AJS, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Staiger C, Curtin EL, Roecker EB, Schultz MK, DeMets DL: Effect of carvedilol on the survival of patients with severe chronic heart failure. New England Journal of Medicine 344:1651-1658, 2001.
Packer M, Fowler MB, Roecker EB, Coats AJS, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Staiger C, Holcslaw TL, Amann-Zalan I, DeMets DL: Effect of carvedilol on the morbidity of patients with severe chronic heart failure. Circulation 106:2194-2199, 2002.
Krum H, Roecker EB, Mohacsi P, Rouleau JL, Tendera M, Coats AJS, Katus HA, Fowler MB, Packer M: Effects of initiating carvedilol in patients with severe chronic heart failure. Journal of the American Medical Association 289:712-718, 2003.
Rouleau, J.L., Roecker, E.B., Tendera, M., Mohacsi, P., Krum, H., Katus, H.A., Fowler, M.B., Coats, A.J.S. and Packer, M. Influence of pretreatment systolic blood pressure on the effects of carvedilol in patients with severe chronic heart failure: The COPERNICUS study, Journal of the American College of Cardiology 43:1423-1429,2004.
Krum, H., Haas, S., Eichhorn E., Ghali, J., Gilbert E., Lechat, P., Packer, M., Roecker, E., Verkenne, P., Wedel, H., Wilkstrand J. Prognostic benefit of beta-blockers in patients not receiving ACE inhibitors. European Heart Journal 26:2154-2158, 2005.
Lowes, B.D., Shakar, S.F., Metra, M., Feldman, A.M., Eichhorn, E., Freytag, J.W., Gerber, M.J., Liard, J-F., Hartman, C., Gorcznski, R., Evans, G., Linseman, J.V., Stewart, J., Robertson, A.D., Roecker, E.B., DeMets, D.L. and Bristow, M.R. Rationale and design of the enoximone clinical trials program. Journal of Cardiac Failure 11:659-669, 2005.
Krum, H., Mohacsi, P., Katus, H.A., Tendera, M., Rouleau, J.L., Fowler, M.B., Coats, A.J., Roecker, E.B. and Packer, M. Are beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study, American Heart Journal 151:55-61, 2006..
 Search PubMed for other publications by Ellen Roecker
|
